Preparation and bioevaluation of a novel 99m Tc-labelled propylene amine oxime (PnAO) containing two 4-methyl-2-nitroimidazole groups as a promising tumor hypoxia imaging agent
Shuo Li,Taiwei Chu
DOI: https://doi.org/10.1016/j.bmcl.2024.129773
IF: 2.94
2024-04-28
Bioorganic & Medicinal Chemistry Letters
Abstract:Hypoxia is a common phenomenon in solid tumors, and its presence inhibits the efficacy of tumor chemotherapy and radiotherapy. Accurate measurement of hypoxia before tumor treatment is essential. Three propylene amine oxime (PnAO) derivatives with different substituents attached to 2-nitroimidazole were synthesized in the work, they are 3,3,9,9-tetramethyl-1,11-bis(4-bromo-2-nitro-1 H -imidazol-1-yl)-4,8-diazaundecane-2,10-dione dioxime (Br2P2), 3,3,9,9-tetramethyl-1,11-bis(4-methyl-2-nitro-1 H -imidazol-1-yl)-4,8-diazaundecane-2,10-dione dioxime (Me2P2) and 3,3,9,9-tetramethyl-1,11-bis(4,5-dimethyl-2-nitro-1 H -imidazol-1-yl)-4,8-diazaundecane-2,10-dione dioxime (2Me2P2). The three compounds were radiolabeled with 99m Tc to give three complexes([ 99m Tc]Tc-Br2P2, [ 99m Tc]Tc-Me2P2 and [ 99m Tc]Tc-2Me2P2) with good in vitro stability. [ 99m Tc]Tc-Me2P2 with a more suitable reduction potential had the highest hypoxic cellular uptake, compared with [ 99m Tc]Tc-2P2 that have been previously reported, [ 99m Tc]Tc-Br2P2 and [ 99m Tc]Tc-2Me2P2. Biodistribution results in S180 tumor-bearing mice demonstrated that [ 99m Tc]Tc-Me2P2 had the highest tumor-to-muscle (T/M) ratio (12.37 ± 1.16) at 2 h in the four complexes. Autoradiography and immunohistochemical staining results revealed that [ 99m Tc]Tc-Me2P2 specifically targeted tumor hypoxic regions. The SPECT/CT imaging results showed that [ 99m Tc]Tc-Me2P2 could target the tumor site. [ 99m Tc]Tc-Me2P2 may become a potential hypoxia imaging agent.
chemistry, medicinal, organic